Study to Evaluate Adverse Events and Change in Disease Activity When Intravenously (IV) Infused Livmoniplimab is Used in Combination With IV Infused Budigalimab in Adult Participants With Urothelial Carcinoma (UC)

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

January 20, 2025

Primary Completion Date

March 31, 2027

Study Completion Date

August 31, 2028

Conditions
Urothelial Carcinoma
Interventions
DRUG

Livmoniplimab

Intravenous (IV) Infusion

DRUG

Budigalimab

IV Infusion

DRUG

Docetaxel

IV Infusion

DRUG

Paclitaxel

IV Injection

DRUG

Docetaxel

IV Injection

DRUG

Paclitaxel

IV Infusion

DRUG

Gemcitabine

IV Infusion

Trial Locations (37)

10029

Icahn School of Medicine at Mount Sinai /ID# 270272, New York

10408

National Cancer Center /ID# 270453, Goyang-si

13273

Institut Paoli-Calmettes /ID# 270580, Marseille

19713

Medical Oncology Hematology Consultants /ID# 271347, Newark

28033

Hospital MD Anderson Cancer Center Madrid /ID# 269780, Madrid

28040

Hospital Clinico San Carlos /ID# 269786, Madrid

33705

Florida Cancer Specialists - North /ID# 271215, St. Petersburg

37203

SCRI Oncology Partners /ID# 270439, Nashville

41013

Hospital Universitario Virgen del Rocio /ID# 269782, Seville

43210

The Ohio State University /ID# 271349, Columbus

44106

University Hospitals Cleveland Medical Center /ID# 271010, Cleveland

58128

Chonnam National University Hwasun Hospital /ID# 271299, Hwasun-gun

72762

Highlands Oncology Group - Springdale /ID# 270290, Springdale

78731

Texas Oncology - Austin Central /ID# 271284, Austin

84124

Utah Cancer Specialist /ID# 270810, Salt Lake City

92151

Hôpital Foch /ID# 270573, Suresnes

94158

University of California San Francisco - Mission Bay /ID# 270289, San Francisco

94800

Institut Gustave Roussy /ID# 270575, Villejuif

3525408

Rambam Health Care Campus /ID# 270105, Haifa

4428164

Meir Medical Center /ID# 270108, Kfar Saba

4941492

Rabin Medical Center /ID# 270107, Petah Tikva

5265601

The Chaim Sheba Medical Center /ID# 270096, Ramat Gan

6423906

Tel Aviv Sourasky Medical Center /ID# 270106, Tel Aviv

06510

Yale University School of Medicine /ID# 270449, New Haven

G1J 1Z4

Centre Hospitalier Affilié Universitaire de Québec - Hôpital de l'Enfant-Jésus /ID# 271635, Québec

036-8563

Hirosaki University Hospital /ID# 270531, Hirosaki

960-1295

Fukushima Medical University Hospital /ID# 270752, Fukushima

305-8576

University of Tsukuba Hospital /ID# 270354, Tsukuba

920-8641

Kanazawa University Hospital /ID# 270473, Kanazawa

60-185

Aidport Sp. z o.o. /ID# 270049, Skórzewo

02-781

Narodowy Instytut Onkologii Im. Marii Sklodowskiej-Curie Panstwowy Instytut Bada /ID# 270046, Warsaw

03722

Yonsei University Health System Severance Hospital /ID# 270317, Seoul

05505

Asan Medical Center /ID# 270898, Seoul

06351

Samsung Medical Center /ID# 270318, Seoul

08003

Parc de Salut Mar - Hospital del Mar /ID# 270173, Barcelona

08035

Hospital Universitario Vall d'Hebron /ID# 269783, Barcelona

08036

Hospital Clinic de Barcelona /ID# 269789, Barcelona

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AbbVie

INDUSTRY